/Companies

Respira Therapeutics

Albuquerque, US · Delaware corporation · 2 known investors

Find your way into Respira Therapeutics

Sign up to see every warm intro you have to Respira Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Respira Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MF
Matthew FranklinExecutive
RM
Robert M. CurtisExecutive
AC
Andrew ClarkNamed on SEC filing

Board

DB
David BlivinBoard director
BP
Brian P. BirkBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$9.1M disclosed across 1 round · 2017

▶$9.1MraisedApr 2017 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David BlivinDirector
  • Matthew FranklinExecutive Officer
  • Andrew ClarkDirector
  • Robert M. CurtisExecutive Officer, Director
  • Brian P. BirkDirector
Offering amount
$9.4M
Amount sold
$9.1M
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Respira Therapeutics's investors?
Respira Therapeutics's investors include Cottonwood Technology Fund, Samsara BioCapital.
How much funding has Respira Therapeutics raised?
Respira Therapeutics has disclosed $9.1M raised across 1 round.
Where is Respira Therapeutics headquartered?
Respira Therapeutics is headquartered in Albuquerque, US.